Jakinibs in both topical and systemic ingestion are proven to stimulate DP cell proliferation in vitro, accelerated hair growth in mice engineered to have AA, human skin grafted onto the backs of mice, and the oral drug has grown hair in humans with AA. The mice studies are over, and it is time for Aclaris to test both oral and topical formulations on people with AA and Androgenetic Alopecia. The topical form of the drug for humans will take some expertise to develop in order to penetrate human scalp and reach the depth of hair follicles required and remain there longer than a few minutes at a time. No shortcuts in science.
And UCLA researchers have patented two new drugs, RCGD423 and UK5099. These drugs activate JAK-Stat leading to the increased production of lactate and, in turn, drives hair follicle stem cell activation and hair growth. These drugs have only been tested in lab mice not humans. Again, no shortcuts in science. Same goes for Tsuji who will eventually need to test his method in humans.
If anyone tells you they know what the clinical trial results will be before they even begin, they are lying. What we do know for sure is that once a cellular signalling pathway for hair growth is discovered, the first thing they look for are drugs to affect the same pathways in order to turn hair growth on or off. Why drugs? It's because if we want to cross a river, we might get by with floating a canoe and not an aircraft carrier. Hair multiplication, HSC, PRP, gene therapy etc might be overkill compared to a least invasive and least costly solution, which would be small molecule drugs.